3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Breast Neoplasms
2
Rhabdomyosarcoma
1
Retinoblastoma
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, AIDS-Related
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia
1
Infiltrating Bladder Urothelial Carcinoma
1
Hodgkin Disease
1
HER2-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Blast Crisis
1
Amyloidosis
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
pertuzumab
3
Trastuzumab
3
Paclitaxel
2
Docetaxel
2
tucatinib
1
trastuzumab deruxtecan
1
pegfilgrastim
1
atezolizumab
1
Carboplatin
1
Ado-Trastuzumab Emtansine
1
ARX788
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
HER2-positive Breast Cancer
×
pegfilgrastim
×
Clear all
NCT03571633
2025-11-26
BREASTIMMU02
Centre Leon Berard
Phase 2
Active not recruiting
90 enrolled